



Pelvic floor disorders (PFDs) such as incontinence and prolapse, significantly impact women's quality of life. Artificial Intelligence (AI), particularly Machine Learning (ML), offers promising solutions to enhance diagnosis, personalize treatment, and streamline research in this complex field.
AI's potential lies in its ability to process vast datasets and identify patterns. Key AI concepts include Machine Learning (ML), which is characterized as “supervised,” “unsupervised,” and “deep learning”; Natural Language Processing (NLP); and Computer Vision. Urogynecology presents unique challenges: diagnostic complexity, treatment personalization, subjectivity in interpretations, and data richness. AI can address these by automating image analysis, standardizing urodynamic interpretation, and predicting risks from electronic health records (EHRs).
Current AI applications could enhance urogynecology by enhancing diagnostics. Computer vision algorithms have been demonstrated to automate measurements from pelvic floor ultrasound and MRI. ML models can analyze urodynamic data to classify patterns and predict treatment response. NLP can extract information from EHRs and patient-reported outcomes (PROs) to predict risks and track symptom progression.
Machine learning models possess the capability to forecast treatment efficacy, differentiate between conservative management and surgical interventions, and assess the likelihood of recurrence or complications. Furthermore, AI could enhance surgical planning by simulating various approaches and providing recommendations for surgical techniques tailored to individual patient data.
Surgical innovation potentially benefits from AI in endoscopic surgery, enhancing visualization and providing intraoperative guidance. AI can also accelerate research by analyzing large datasets to identify risk factors and uncover complex interactions. Patient management is currently augmented through AI-powered chatbots and symptom monitoring apps.
Despite the potential, challenges exist. Data quality, bias, privacy, and security are critical concerns. Clinical trust requires algorithm transparency and explainability. Validation, regulatory approval, and seamless workflow integration are essential. Ethical considerations include accountability, deskilling, patient trust, and cost accessibility.
Quality improvement initiatives in health care involve studying previous events for learning and practice improvement. Artificial intelligence models are developed from historical data. In healthcare, outcomes are optimal when surgeons act judiciously and act decisively in response to situational needs. Future research should focus on training AI to emulate the essential modifications implemented by physicians, enabling AI to adapt to varying environments similarly to clinicians.
The incorporation of AI systems into the healthcare framework will transform the responsibilities of urogynecologic surgeons. AI technologies are anticipated to aid clinicians in making swifter and more precise judgments while providing individualized patient care. Nonetheless, insufficient information regarding the utilization of complicated AI systems and the interpretation of their results may place a significant cognitive burden on surgeons. Consequently, medical education must integrate essential AI training for urogynecologists to enhance their comprehension of AI systems' fundamental operations and to derive clinically significant insights from AI